Agonist-induced Phosphorylation of the Angiotensin II (AT1A) Receptor Requires Generation of a Conformation That Is Distinct from the Inositol Phosphate-signaling State*

G protein-coupled receptors are thought to isomerize between distinct inactive and active conformations, an idea supported by receptor mutations that induce constitutive (agonist-independent) activation. The agonist-promoted active state initiates signaling and, presumably, is then phosphorylated and internalized to terminate the signal. In this study, we examined the phosphorylation and internalization of wild type and constitutively active mutants (N111A and N111G) of the type 1 (AT1A) angiotensin II receptor. Cells expressing these receptors were stimulated with angiotensin II (AngII) and [Sar1,Ile4,Ile8]AngII, an analog that only activates signaling through the constitutive receptors. Wild type AT1A receptors displayed a basal level of phosphorylation, which was stimulated by AngII. Unexpectedly, the constitutively active AT1A receptors did not exhibit an increase in basal phosphorylation nor was phosphorylation enhanced by AngII stimulation. Phosphorylation of the constitutively active receptors was unaffected by pretreatment with the non-peptide AT1 receptor inverse agonist, EXP3174, and was not stimulated by the selective ligand, [Sar1,Ile4,Ile8]AngII. Paradoxically, [Sar1,Ile4,Ile8]AngII produced a robust (∼85% of AngII), dose-dependent phosphorylation of the wild type AT1A receptor at sites in the carboxyl terminus similar to those phosphorylated by AngII. Moreover, internalization of both wild type and constitutive receptors was induced by AngII, but not [Sar1,Ile4,Ile8]AngII, providing a differentiation between the phosphorylated and internalized states. These data suggest that the AT1A receptor can attain a conformation for phosphorylation without going through the conformation required for inositol phosphate signaling and provide evidence for a transition of the receptor through multiple states, each associated with separate stages of receptor activation and regulation. Separate transition states may be a common paradigm for G protein-coupled receptors.

[1]  P. Leff,et al.  A Three‐State Receptor Model: Predictions of Multiple Agonist Pharmacology for the Same Receptor Type a , 1998, Annals of the New York Academy of Sciences.

[2]  B. Maigret,et al.  Mutation of Asn111 in the Third Transmembrane Domain of the AT1A Angiotensin II Receptor Induces Its Constitutive Activation* , 1997, The Journal of Biological Chemistry.

[3]  R. Lefkowitz,et al.  Constitutively active mutants of the alpha 2-adrenergic receptor. , 1993, The Journal of biological chemistry.

[4]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[5]  R. Graham,et al.  Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. , 1996, Molecular pharmacology.

[6]  M. Caron,et al.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.

[7]  M. Caron,et al.  Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features. , 1999, Molecular pharmacology.

[8]  E. sanders-Bush,et al.  Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. , 1995, Molecular pharmacology.

[9]  P. Corvol,et al.  Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements , 1994, FEBS letters.

[10]  M. Zuscik,et al.  Identification of a Conserved Switch Residue Responsible for Selective Constitutive Activation of the β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.

[11]  H. Hasegawa,et al.  Prostaglandin E receptor EP3γ isoform, with mostly full constitutive Gi activity and agonist‐dependent Gs activity , 1996, FEBS letters.

[12]  T. Thekkumkara,et al.  Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: MOLECULAR MECHANISMS OF ANGIOTENSIN II (AT1a) RECEPTOR ENDOCYTOSIS , 1996, Clinical and experimental pharmacology & physiology.

[13]  R. Leurs,et al.  Agonist-independent regulation of constitutively active G-protein-coupled receptors. , 1998, Trends in biochemical sciences.

[14]  P. Leff Inverse agonism: theory and practice. , 1995, Trends in pharmacological sciences.

[15]  S. Swillens How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown. , 1992, Trends in pharmacological sciences.

[16]  P. Leff,et al.  A three-state receptor model of agonist action. , 1997, Trends in pharmacological sciences.

[17]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[18]  P. Leff,et al.  The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.

[19]  P. Corvol,et al.  Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Terri L. Gilbert,et al.  Multiple activation steps of the N-formyl peptide receptor. , 1999, Biochemistry.

[21]  S. Miura,et al.  Role of Aromaticity of Agonist Switches of Angiotensin II in the Activation of the AT1 Receptor* , 1999, The Journal of Biological Chemistry.

[22]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[23]  X. P. Liu,et al.  The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. , 1996, Biochemistry.

[24]  K. Baker,et al.  Stable expression of a truncated AT1A receptor in CHO-K1 cells. The carboxyl-terminal region directs agonist-induced internalization but not receptor signaling or desensitization. , 1995, The Journal of biological chemistry.

[25]  D. Oprian,et al.  Constitutive activation of opsin: interaction of mutants with rhodopsin kinase and arrestin. , 1995, Biochemistry.

[26]  L. Hunyady,et al.  A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor (*) , 1995, The Journal of Biological Chemistry.

[27]  A. Seibold,et al.  β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists* , 1997, The Journal of Biological Chemistry.

[28]  L. Hunyady,et al.  Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. , 1998, Molecular pharmacology.

[29]  S. Miura,et al.  Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). , 1998, Biochemistry.

[30]  T. Thekkumkara,et al.  Angiotensin II Receptor Endocytosis Involves Two Distinct Regions of the Cytoplasmic Tail , 1995, The Journal of Biological Chemistry.

[31]  K. Jarnagin,et al.  Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation. , 1996, Biochemistry.

[32]  R. Lefkowitz,et al.  A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. , 1994, Proceedings of the National Academy of Sciences of the United States of America.